(Q48762266)

15 February 2018

title

Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia (English)

1 reference

15 February 2018

0 references

0 references

0 references

Sjögren M

1 reference

15 February 2018

author name string

Wallin A

series ordinal

1 reference

15 February 2018

publication date

1 November 2001

1 reference

15 February 2018

Mechanisms of Ageing and Development

published in

1 reference

15 February 2018

volume

122

1 reference

15 February 2018

issue

1 reference

15 February 2018

page(s)

1937-1949

1 reference

15 February 2018

'Vascular Depression' Hypothesis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Is "Parkinson's disease" one disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution?

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

1 reference

7 January 2021

Tau protein and the neurofibrillary pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Subcortical vascular dementia as a specific target for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

1 reference

7 January 2021

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

A method for the identification of apolipoprotein E isoforms employing chemical precipitation and flat bed isoelectric focusing in agarose

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Cognition and white matter hyperintensities in older depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Tau Protein in Cerebrospinal Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Pathogenesis of leukoaraiosis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Cerebrospinal fluid proteins in patients with leucoaraiosis: possible abnormalities in blood-brain barrier function

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Cerebrovascular disease and late life depression: an age old association revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Effects of enzymatic blood defibrination in subcortical arteriosclerotic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Neurofilament protein levels in CSF are increased in dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Cerebral Perfusion in Hypertensives with Carotid Artery Stenosis: A Comparative Study of Lacidipine and Hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Characteristics of growth-associated polypeptides in regenerating toad retinal ganglion cell axons

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimerʼs disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Heterogeneity of vascular dementia: mechanisms and subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Decreased myelin lipids in Alzheimer's disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Blood brain barrier function in vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900306-2

7 January 2021

10.1016/S0047-6374(01)00306-2

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018